The Impact of COVID-19 is included in mRNA Vaccine Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
mRNA Vaccine Trends and Forecast
The future of the global mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets. The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030 with a CAGR of 8.3% from 2024 to 2030. The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
mRNA Vaccine by Segment
The study includes a forecast for the global mRNA vaccine by type, application, end use, and region.
mRNA Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:
• Self-Amplifying mRNA Vaccines (SAM)
• Conventional Non-Amplifying mRNA Vaccines
mRNA Vaccine Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Cancer Immunotherapy
• Allergy Tolerization
• Therapeutic Vaccines
mRNA Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
• Hospitals & Clinics
• Research Laboratories
• Others
mRNA Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of mRNA Vaccine Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies mRNA vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the mRNA vaccine companies profiled in this report include-
• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo
mRNA Vaccine Market Insights
Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.
Within this market, hospital & clinic will remain the largest segment due to growing patients preference for this facilities because of the convenient access to vaccinations, availability of trained medical personnel, and existence of advanced healthcare infrastructure.
North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.
Features of the Global mRNA Vaccine Market
Market Size Estimates: mRNA vaccine market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: mRNA vaccine market size by type, application, end use, and region in terms of value ($B).
Regional Analysis: mRNA vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, end uses, and regions for the mRNA vaccine market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the mRNA vaccine market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the mRNA vaccine market size?
Answer: The global mRNA vaccine market is expected to reach an estimated $26.8 billion by 2030.
Q.2 What is the growth forecast for mRNA vaccine market?
Answer: The global mRNA vaccine market is expected to grow with a CAGR of 8.3% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the mRNA vaccine market?
Answer: The major drivers for this market are soaring demand for new vaccines and therapeutics and rising cases of chronic and infectious diseases.
Q4. What are the major segments for mRNA vaccine market?
Answer: The future of the mRNA vaccine market looks promising with opportunities in the hospital & clinic and research laboratory markets.
Q5. Who are the key mRNA vaccine market companies?
Answer: Some of the key mRNA vaccine companies are as follows:
• Pfizer
• Moderna
• BioNTech
• GlaxoSmithKline
• Daiichi Sankyo
Q6. Which mRNA vaccine market segment will be the largest in future?
Answer: Lucintel forecasts that cancer immunotherapy is expected to witness highest growth over the forecast period.
Q7. In mRNA vaccine market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest regiondue to augmenting prevalence of infectious diseases among population, existence of robust healthcare infrastructure, and presence of key players in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the mRNA vaccine market by type (self-amplifying mRNA vaccines (SAM) and conventional non-amplifying mRNA vaccines), application (cancer immunotherapy, allergy tolerization, and therapeutic vaccines), end use (hospitals & clinics, research laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Mrna Vaccine Market, Mrna Vaccine Market Size, Mrna Vaccine Market Growth, Mrna Vaccine Market Analysis, Mrna Vaccine Market Report, Mrna Vaccine Market Share, Mrna Vaccine Market Trends, Mrna Vaccine Market Forecast, Mrna Vaccine Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global mRNA Vaccine Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global mRNA Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global mRNA Vaccine Market by Type
3.3.1: Self-Amplifying mRNA Vaccines (SAM)
3.3.2: Conventional Non-Amplifying mRNA Vaccines
3.4: Global mRNA Vaccine Market by Application
3.4.1: Cancer Immunotherapy
3.4.2: Allergy Tolerization
3.4.3: Therapeutic Vaccines
3.5: Global mRNA Vaccine Market by End Use
3.5.1: Hospitals & Clinics
3.5.2: Research Laboratories
3.5.3: Others
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global mRNA Vaccine Market by Region
4.2: North American mRNA Vaccine Market
4.2.1: North American mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
4.2.2: North American mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
4.3: European mRNA Vaccine Market
4.3.1: European mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
4.3.2: European mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
4.4: APAC mRNA Vaccine Market
4.4.1: APAC mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
4.4.2: APAC mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
4.5: ROW mRNA Vaccine Market
4.5.1: ROW mRNA Vaccine Market by Application: Cancer Immunotherapy, Allergy Tolerization, and Therapeutic Vaccines
4.5.2: ROW mRNA Vaccine Market by End Use: Hospitals & Clinics, Research Laboratories, and Others
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global mRNA Vaccine Market by Type
6.1.2: Growth Opportunities for the Global mRNA Vaccine Market by Application
6.1.3: Growth Opportunities for the Global mRNA Vaccine Market by End Use
6.1.4: Growth Opportunities for the Global mRNA Vaccine Market by Region
6.2: Emerging Trends in the Global mRNA Vaccine Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global mRNA Vaccine Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global mRNA Vaccine Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Pfizer
7.2: Moderna
7.3: BioNTech
7.4: GlaxoSmithKline
7.5: Daiichi Sankyo
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - mRNA Vaccine Market Report.